Product
Patsnap Eureka
For R&D, Patsnap Eureka makes reading and utilizing patents & technical documents easy.
Patsnap Eureka AIR
Designed for self-driven R&D workflows. Generate viable solutions, solve complex R&D challenges, empower your innovation with AI.
Patsnap Eureka Materials
Designed for material experts only. Revolutionize your material R&D, from search, analyze, to developing new materials.
Feature
TechResearch
Generate reliable direction feasibility study reports for your R&D in just a few steps.
TechSeek
Discover and master advanced knowledge NOW. Basics, ideas, possibilities, all at once.
TechMind
As an expert in R&D Theories, TechMind can generates customized viable solutions instantly.
TechRisk
Analyze your overall solution with one click, know your potential R&D risks in advance.
TechMonitor
Get weekly tech updates, stay abreast of the latest tech innovations and key insights.
Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
47 results about "Pms premenstrual syndrome" patented technology
Efficacy Topic
Property
Owner
Technical Advancement
Application Domain
Technology Topic
Technology Field Word
Patent Country/Region
Patent Type
Patent Status
Application Year
Inventor
Premenstrual syndrome (PMS) Overview. Premenstrual syndrome (PMS) has a wide variety of signs and symptoms, including mood swings, tender breasts, food cravings, fatigue, irritability and depression. It's estimated that as many as 3 of every 4 menstruating women have experienced some form of premenstrual syndrome.
Premenstrual dysphoric disorder medication
InactiveUS20050250746A1Effective treatmentBiocideOrganic active ingredientsANXIETY COMPLEXPhysiology
Owner:IAMMATTEO MATTHEW
Use of progesterone receptor modulators
A progesterone receptor modulator of the structure is provided. Use of compositions containing this compound for contraception, hormone replacement therapy, treating hormone-dependent disease, synchronizing estrus, treating dysmenorrhea, treating dysfunctional uterine bleeding, inducing amenorrhea, or treating symptoms of premenstrual syndrome and premenstrual dysphoric disorder in a mammal are described.
Owner:WYETH LLC
Therapeutic uses of milk mineral fortified food products
Food products fortified with a therapeutically effective amount of milk mineral are administered for the treatment of high blood pressure, stroke, obesity, kidney stones, colon cancer, breast cancer, head and neck tumors, premenstrual syndrome, postpartum depression, hypertensive disorders of pregnancy, Type-2 diabetes, depression, asthma, inflammatory bowel disease, attention deficit disorder, migraine headaches, kidney disease, hypercholesterolaemia, congestive heart failure, or immune deficiency.
Owner:GLANBIA FOODS
Quinoline derivatives, their production and use
The present compounds are intermediates for the preparation of quinoline derivatives and compositions having gonadotropin-releasing hormone antagonistic activity useful as propylactics or therapeutic agent for the prevention or treatment of several hormone dependent diseases, for example, a sex hormone dependent cancer (e.g. prostatic cancer, uterine or cervical cancer, breast cancer, pituitary adenoma), benign prostatic hypertrophy, myoma of the uterus, endometriosis, precocious puberty, amenorrhea, premenstrual syndrome, polycystic ovary syndrome and acne vulgaris; are effective as a fertility controlling agent in both sexes (e.g. a pregnancy controlling agent and a menstrual cycle controlling agent); can be used as a male or female contraceptive, as an ovulation-inducing agent; can be used as an infertility treating agent by using a rebound effect owing to a stoppage of administration thereof; and are useful for modulating estrous cycles in animals in the field of animal husbandry, as agents for improving the quality of edible meat or promoting the growth of animals, and as agents for promoting spawning in fish.
Owner:TAKEDA PHARMA CO LTD
Composition comprising cocoa
InactiveUS20040005347A1Improve obesityReducing appetite and carbohydrate cravingBiocideOrganic active ingredientsDecreased LibidoAmine receptor
Owner:NV NUTRICIA
Combination of atypical antipsychotics and 5HT-1B receptor antagonists
InactiveUS20050256112A1Reduce morbidityDifferent recognizableNervous disorderMetabolism disorderDiseaseHeadaches
The present invention relates to a pharmaceutical composition for treating, for example, a disorder or condition selected from the group consisting of hypertension, depression, generalized anxiety disorder, phobias, posttraumatic stress disorder, avoidant personality disorder, sexual dysfunction, eating disorders, obesity, chemical dependencies, cluster headache, migraine, pain, Alzheimer's disease, obsessive-compulsive disorder, panic disorder, memory disorders, Parkinson's diseases, endocrine disorders, cerebellar ataxia, gastrointestinal tract disorders, negative symptoms of schizophrenia, premenstrual syndrome, Fibromyalgia Syndrome, stress incontinence, Tourette syndrome, trichotillomania, kleptomania, male impotence, cancer, chronic paroxysmal hemicrania and headache in a mammal, preferably a human, comprising (i) an atypical antipsychotic or a pharmaceutically acceptable salt thereof, (ii) a 5-HT1B receptor antagonist or a pharmaceutically acceptable salt thereof, wherein the 5-HT1B receptor antagonist is selected from the group consisting of (A) a compound of the formula I as described in the specification and (B) a compound of the formula II as described in the specification, and optionally (iii) a pharmaceutically acceptable carrier.
Owner:PFIZER INC
Compositions containing policosanol and chromium and/or chromium salts and their pharmaceutical uses
InactiveUS20060024383A1Increasing lean body massLower blood sugar levelsHeavy metal active ingredientsBiocideCoronary heart diseaseHypoglycemia
A composition is provided which contains policosanol and chromium and / or chromium salts and which may be used for treating, preventing and or reducing metabolic syndrome, hypercholesterolemia and hypoglycemia related diseases, total cholesterol, LDL-cholesterol, LDL / HDL ratio, triglycerides, coronary heart disease (heart attacks and strokes), inflammation, deep-vein thrombosis, immunoregulatory diseases, cardiovascular diseases, obesity, insulin resistance, dyslipidemia, raised blood pressure, fatigue, premenstrual syndrome, anxiety, depression and / or neurodegenerative disorders, and / or raising HDL cholesterol and / or lean body mass in humans and animals. The method comprises administering policosanol and chromium and / or chromium salts which together effectively lower blood glucose levels and lower the LDL / HDL cholesterol ratio. Typically, the administered composition includes about 0.1-10:1 parts by weight of policosanol to chromium and / or chromium salts.
Owner:WYETH
Condensed-ring thiophene derivatives, their production and use
A gonadotropin-releasing hormone antagonistic composition, which comprises an optionally substituted condensed-bicyclic compound consisting of a homo or hetero 5 to 7 membered ring and a homo or hetero 5 to 7 membered ring is effective as a propylactic or therapeutic agent for the prevention or treatment of several hormone dependent diseases, for example, a sex hormone dependent cancer (e.g. prostatic cancer, cancer of uterine cervix, breast cancer, pituitary adenoma), benign prostatic hypertrophy, myoma of the uterus, endometriosis, precocious puberty, amenorrhea, premenstrual syndrome, polycystic ovary syndrome and acne vulgaris; is effective as a fertility controlling agent in both sexes (e.g. a pregnancy controlling agent and a menstrual cycle controlling agent); can be used as a contraceptive of male or female, as an ovulation-inducing agent of female; can be used as an infertility treating agent by using a rebound effect owing to a stoppage of administration thereof; is useful as modulating estrous cycles in animals in the field of animal husbandry, as an agent fro improving the quality of edible meat or promoting the growth of animals; is useful as an agent of spawning promotion in fish.
Owner:TAKEDA PHARMA CO LTD
Micronutrient supplement with calcium, vitamin D or calcium & vitamin D combination for premenstrual syndrome, postpartum depression, depression and panic attacks
A bolus dose supplement, foodstuff, beverage and beverage concentrate with calcium and vitamin D for the treatment and prevention of PMS, panic attacks, and postpartum depression. The combination of adequate calcium and vitamin D is provided as a multi-vitamin and mineral supplement. The bolus dose is comprised of 2 main ingredients calcium and vitamin D at 1000-1500 mg of elemental calcium in the form of carbonate or citrate or gluconate or citrate maleate and 400-20,000 I.U. of parent vitamin D
Owner:THYS JACOBS SUSAN
Polymorphic forms of 1-4-(5-cyanoindol-3-yl) butyl-4-(2-carbamoylbenzofuran-5-yl) piperazine hydrochloride
InactiveCN1516699ALow hygroscopicityEasy to compressOrganic active ingredientsNervous disorderSide effectCerebral infarction
The invention relates to new crystalline modifications of the hydrochloride of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine, crystalline modification of the dihydrochloride of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine and amorphous 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine hydrochloride which are suitable in particular for the preparation of solid medicaments for the treatment or prevention of depressive disorders, anxiety disorders, bipolar disorders, mania, dementia, substance-related disorders, sexual dysfunctions, eating disorders, obesity, fibromyalgia, sleeping disorders, psychiatric disorders, cerebral infarct, tension, for the therapy of side-effects in the treatment of hypertension, cerebral disorders, chronic pain, acromegaly, hypogonadism, secondary amenorrhea, premenstrual syndrome and undesired puerperal lactation.
Owner:MERCK PATENT GMBH
Ligands for Nicotinic Acetylcholine Receptors, and Methods of Making and Using Them
ActiveUS20080132486A1Easily determining tailoringSimple designBiocideNervous disorderDiseaseAlcoholisms
One aspect of the present invention relates to heterocyclic compounds that are ligands for nicotinic acetylcholine receptors. A second aspect of the invention relates to the use of a compound of the invention for modulation of a mammalian nicotinic acetylcholine receptor. The present invention also relates to the use of a compound of the invention for treating a mammal suffering from Alzheimer's disease, Parkinson's disease, dyskinesias, Tourette's syndrome, schizophrenia, attention deficit disorder, anxiety, pain, depression, obsessive compulsive disorder, chemical substance abuse, alcoholism, memory deficit, pseudodementia, Ganser's syndrome, migraine pain, bulimia, obesity, premenstrual syndrome or late luteal phase syndrome, tobacco abuse, post-traumatic syndrome, social phobia, chronic fatigue syndrome, premature ejaculation, erectile difficulty, anorexia nervosa, disorders of sleep, autism, mutism or trichtillomania.
Owner:THE JOHN HOPKINS UNIV SCHOOL OF MEDICINE +1
Method for selectively inhibiting reuptake of serotonin and norepinephrine using yeast extract
InactiveUS20060140974A1Reduce premenstrual syndromes (PMSSlow downBiocideMicroorganismsAnti-Anxiety AgentsAnti stress
A yeast extract or yeast-derived bioactive peptide having an activity of selectively inhibiting reuptake of serotonin and norepinephrine, which can be effectively used in preventing or treating various diseases related to reuptake of serotonin and norepinephrine, especially depression, anxiety, stress, fatigue and obesity are provided. Also, a yeast extract or yeast-derived bioactive peptide having activities as an anti-stress agent, an anti-fatigue agent, premenstrual syndrome (PMS) and menstrual pain relaxants, and a brain-neurotrophic factor, and a method for preparing the bioactive peptide are provided. The yeast extract or yeast-derived bioactive peptide is effective in relieving stress, nervousness, anxiety, tension, insomnia, fatigue, and imbalance in the autonomic nerve regulation. Therefore, the yeast extract or yeast-derived bioactive peptide is vailable as an anti-depression agent, an anti-anxiety agent, an anti-stress agent, an anti-fatigue agent, an anti-obesity agent, premenstrual syndrome and menstrual pain relaxants, a bain-neurotrophin, and a source of active foods having these activities.
Owner:LEE MOON SUP +1
Ligands for nicotinic acetylcholine receptors, and methods of making and using them
InactiveUS8030300B2Easily determining tailoringSimple designBiocideNervous disorderDiseaseAlcoholisms
One aspect of the present invention relates to heterocyclic compounds that are ligands for nicotinic acetylcholine receptors. A second aspect of the invention relates to the use of a compound of the invention for modulation of a mammalian nicotinic acetylcholine receptor. The present invention also relates to the use of a compound of the invention for treating a mammal suffering from Alzheimer's disease, Parkinson's disease, dyskinesias, Tourette's syndrome, schizophrenia, attention deficit disorder, anxiety, pain, depression, obsessive compulsive disorder, chemical substance abuse, alcoholism, memory deficit, pseudodementia, Ganser's syndrome, migraine pain, bulimia, obesity, premenstrual syndrome or late luteal phase syndrome, tobacco abuse, post-traumatic syndrome, social phobia, chronic fatigue syndrome, premature ejaculation, erectile difficulty, anorexia nervosa, disorders of sleep, autism, mutism or trichtillomania.
Owner:THE JOHN HOPKINS UNIV SCHOOL OF MEDICINE +1
Compositions containing policosanol and biotin and their pharmaceutical uses
InactiveUS20060020007A1Reducing level level blood glucose levelReduce the ratioBiocideHydroxy compound active ingredientsCoronary heart diseaseHypoglycemia
A composition is provided which contains policosanol and biotin and which may be used for treating, preventing and or reducing metabolic syndrome, hypercholesterolemia and hypoglycemia related diseases, total cholesterol, LDL-cholesterol, LDL / HDL ratio, triglycerides, coronary heart disease (heart attacks and strokes), inflammation, deep-vein thrombosis, immunoregulatory diseases, cardiovascular diseases, obesity, insulin resistance, dyslipidemia, raised blood pressure, fatigue, premenstrual syndrome, anxiety, depression and / or neurodegenerative disorders, and / or raising HDL cholesterol in humans and animals. The method comprises administering policosanol and biotin which together effectively lower blood glucose levels and lower the LDL / HDL cholesterol ratio. Typically, the administered composition includes about 0.1-10:1 parts by weight of policosanol to biotin.
Owner:WYETH LLC
α4 β2 δGABA-A receptors as a strategy for PMS and alcoholism
Owner:THE RES FOUND OF STATE UNIV OF NEW YORK
Vitex trifolia extract and its preparing method and use
InactiveCN1562155AHigh content of active ingredientsQuality controllableUnknown materialsSexual disorderBiotechnologyMethanol water
Two extracts VT-1 and VT-2 of shrub chastetree fruit for treating periodic mastodynia, menalgia and premenstrual syndrome is prepared through extracting in mixture of water and methanol or ethanol, separating by adsorptive resin to remove impurities, and eluting by the aqueous solution of alcohol with different concentrations.
Owner:SECOND MILITARY MEDICAL UNIV OF THE PEOPLES LIBERATION ARMY
Spiroindoline derivatives as gonadotropin- releasing hormone receptor antagonists
Spiroindoline derivatives, process for their preparation and pharmaceutical compositions thereof, their use for the treatment and / or prophylaxis of diseases, and their use for the manufacture of medicaments for the treatment and / or prophylaxis of diseases, especially sex-hormone-related diseases in both men and women, in particularly those selected from the group of endometriosis, uterine fibroids, polycystic ovarian disease, hirsutism, precocious puberty, gonadal steroid-dependent neoplasia such as cancers of the prostate, breast and ovary, gonadotrope pituitary adenomas, sleep apnea, irritable bowel syndrome, premenstrual syndrome, benign prostatic hypertrophy, contraception and infertility (e.g., assisted reproductive therapy such as in vitro fertilization). The present application relates in particular to spiroindoline derivatives as gonadotropin-releasing hormone (GnRH) receptor antagonists.
Owner:BAYER INTELLECTUAL PROPERTY GMBH
Composition having a function for alleviating premenstrual syndrome and menstrual pain
ActiveUS20160367614A1Increase painEasy to useHeavy metal active ingredientsHydroxy compound active ingredientsDrugPms premenstrual syndrome
The present specification relates to a composition which contains ginseng berry extract as an active ingredient. Further, the present specification relates to a composition which contains ginseng berry extract and alleviates premenstrual syndrome and menstrual pain. Further, in the present specification, the composition exhibits the effect of alleviating or improving the symptoms of premenstrual syndrome, and hence can be used as a pharmaceutical composition and food composition.
Owner:AMOREPACIFIC CORP
Medicine composition for relieving symptoms before female menstruation
InactiveCN105213973ANo adverse reactions were foundSignificant effectSexual disorderPlant ingredientsTreatment effectPericarpium citri reticulatae
The invention relates to a medicine composition for relieving symptoms before female menstruation. The medicine composition is prepared from the following raw materials: radix bupleuri, fructus aurantii, cortex albiziae, radix curcumae, rhizoma cyperi, pericarpium citri reticulatae viride, beautiful sweetgum fruit, tangerine seed, angelica, radix paeoniae alba, Szechuan lovage rhizome, poria cocos, pericarpium arecae and liquorice. The medicine composition treats both the symptoms and root causes, is remarkable in treating effect, has a very good effect on treating a premenstrual syndrome, and is broad in application prospect.
Owner:XIANGYU PHARMA
Compositions and methods for alleviating symptoms associated with premenstrual syndrome and premenstrual dysphoric disorder
ActiveUS20130171269A1Improve handlingExtended shelf lifeBiocidePhosphorous compound active ingredientsPhosphatidyl-L-serineRegimen
The present invention discloses pharmaceutical / nutritional compositions and methods for alleviating symptoms associated with premenstrual syndrome (PMS) and premenstrual dysphoric disorder (PMDD). The pharmaceutical / nutritional compositions include at least 2% (w / w) phosphatidyl-L-serine, or salts thereof, out of a total effective composition, as a first effective ingredient; and a suitable amount of at least one bio-available form of magnesium as a second effective ingredient. Preferably, the bio-available form of magnesium is magnesium oxide, magnesium citrate, magnesium hydroxide, magnesium stearate, or a magnesium salt of the phosphatidyl-L-serine. Preferably, the composition further includes a pharmaceutical or nutritional excipient. Preferably, the total effective composition is administrable in a multi-part regimen. Preferably, the total effective composition is administrable by intravenous or oral delivery. Preferably, the pharmaceutical / nutritional composition further includes at least 2% (w / w) phosphatidic acid, or salts thereof, out of the total effective composition, as a first effective ingredient.
Owner:LIPOGEN
Lighting control system
InactiveUS20170065827A1Relieve symptomsElectrical apparatusSurgeryBiological bodyEnvironmental remediation
A lighting control system includes: a biological information obtainer which obtains biological information related to a biological body of a user; an environmental information obtainer which obtains environmental information related to a surrounding environment of the user; a severity determiner which determines a severity of premenstrual syndrome (PMS) based on the biological information obtained by the biological information obtainer and the environmental information obtained by the environmental information obtainer; and a lighting controller which controls a lighting device based on the severity determined by the severity determiner.
Owner:PANASONIC INTELLECTUAL PROPERTY MANAGEMENT CO LTD
Compositions and methods of treatment for alleviating premenstrual syndrome symptoms
ActiveUS8399432B2Improve handlingProlong lifeBiocidePhosphorous compound active ingredientsPhosphatidyl-L-serinePhospholipase
Owner:LIPOGEN
Pharmaceutical preparation with functions of activating blood circulation and dredging collaterals as well as application of pharmaceutical preparation
InactiveCN105213972AEasy to prepareWide range of medicinesSexual disorderPlant ingredientsTangerine FruitCurative effect
The invention relates to a pharmaceutical preparation with functions of activating blood circulation and dredging collaterals as well as an application of the pharmaceutical preparation. The pharmaceutical preparation is prepared from raw materials as follows: Chinese thorowax roots, orange fruits, silktree albizia bark, turmeric root tubers, nutgrass galingale rhizomes, green tangerine peels, beautiful sweetgum fruits, tangerine seeds, Chinese angelica, white peony roots, Szechwan lovage rhizomes, Indian buead, areca peels and liquorice roots. The medicine treats both symptoms and root causes, has the significant curative effect, has the good treatment effect on the premenstrual syndrome and has the broad application prospect.
Owner:XIANGYU PHARMA
Flavonoid new chemical entity, composition and use
PendingCN105837646AEasy to slideEasy to makeAntibacterial agentsOrganic active ingredientsArthritisMicroangiopathy
The invention provides a flavonoid new chemical entity, which has little moisture absorption and good storage stability, and is applicable to preparation of food or health food or drugs for reduction of capillary fragility, treatment or prevention of chronic venous insufficiency, hemorrhoid, scurvy, venous lower limb ulcer, premenstrual syndrome, diabetics' microangiopathy and secondary upper limb lymphedema, cardiovascular diseases, blood glucose and lipid regulation, antisepsis and inflammation reduction, virus resisting, cancer resisting, immunity adjustment, radiation protection, liver protection, rheumatoid arthritis or arthritis resisting, ulcer resisting, phlegm eliminating, asthma relieving, black spots, freckles, free radical resistance, and oxidation resistance.
Owner:刘力
Micronutrient supplement with calcium, vitamin d or calcium & vitamin d combination for premenstrual syndrome, postpartum depression, depression and panic attacks
InactiveUS20090263508A1BiocideOrganic active ingredientsPost-pregnancy depressionMineral supplementation
A bolus dose supplement, foodstuff, beverage and beverage concentrate with calcium and vitamin D for the treatment and prevention of PMS, panic attacks, and postpartum depression. The combination of adequate calcium and vitamin D is provided as a multi-vitamin and mineral supplement. The bolus dose is comprised of 2 main ingredients calcium and vitamin D at 1000-1500 mg of elemental calcium in the form of carbonate or citrate or gluconate or citrate maleate and 400-20,000 I.U. of parent vitamin D
Owner:THYS JACOBS SUSAN
Spiroindoline derivatives for use as gonadotropin-releasing hormone receptor antagonists
InactiveUS20160052936A1Acceptable toxicityEffective treatmentBiocideNervous disorderGonadotropin-releasing hormone receptorPrecocious puberty
Spiroindoline derivatives, processes for their preparation and pharmaceutical compositions thereof, their use for the treatment of diseases, and their use for the manufacture of medicaments for the treatment of diseases, especially sex-hormone-related diseases in both men and women, in particularly those selected from the group of endometriosis, uterine leiomyoma (fibroids), polycystic ovarian disease, menorrhagia, dysmenorrhea, hirsutism, precocious puberty, gonadal steroid-dependent neoplasia such as cancers of the prostate, breast and ovary, gonadotrope pituitary adenomas, sleep apnea, irritable bowel syndrome, premenstrual syndrome, benign prostatic hypertrophy, contraception, infertility and assisted reproductive therapy such as in vitro fertilization. The present application relates in particular to spiroindoline derivatives as gonadotropin-releasing hormone (GnRH) receptor antagonists.
Owner:BAYER PHARMA AG
Pharmaceutical composition for treating premenstrual tension syndrome and preparation method thereof
Premenstrual syndrome (PMS) refers to a group of symptom complex repeatedly occurring 7-14 days before menstruation (namely in a luteal phase of a menstrual cycle), affecting women daily life and work and relating to bodies, spirit and behavior, the symptom disappears naturally after menses, and about 90% of women of child-bearing age are estimated to have at least one PMS. The invention aims to provide a pharmaceutical composition for treating premenstrual tension syndrome and a preparation method thereof. The pharmaceutical composition is composed of radix bupleuri, cape jasmine, malt, radix rhapontied and siphonostegia chinensis. The pharmaceutical composition has the functions of soothing liver and relieving depression, regulating qi to alleviate pain, and promoting blood circulation to regulate menstruation, and is used for liver qi unfavorable prognosis syndrome of the premenstrual tension syndrome. The preparation method of the pharmaceutical composition comprises the steps: extracting and concentrating the pharmaceutical composition with water or an appropriate concentration of ethanol or concentrating after recovery of the ethanol, removing impurities, drying, mixing with suitable auxiliary materials, and preparing a pharmaceutically acceptable preparation.
Owner:北京植物世纪营养品有限公司
Condensed-ring thiophene derivatives, their production and use
Owner:TAKEDA PHARMA CO LTD
Premenstrual calming tablet and preparation process thereof
ActiveCN104740579ANo adverse reactions were foundMedication safetyPill deliverySexual disorderTreatment effectPericarpium citri reticulatae
The invention relates to a premenstrual calming tablet and a preparation process thereof. The preparation is mainly prepared from the following raw materials: radix bupleuri, fructus aurantii, rhizoma zingiberis, radix curcumae, rhizoma cyperi, pericarpium citri reticulatae viride, liquidambar formosana hance, tangerine seed, Chinese angelica, white paeony root, ligusticum wallichii, poria cocos, pericarpium arecae, liquorice and the like which are prepared into the tablet according to the normal method. Based on the prior art, the premenstrual calming tablet is applied according to syndrome, and the components of the traditional Chinese medicines are matched with each other to coordinate efficiency, so that the premenstrual calming tablet is low in cost, good in treatment effect in premenstrual syndrome according to the clinical verification, and wide in application prospect.
Owner:XIANGYU PHARMA
Therapeutic carbohydrate blends for treating and aiding premenstrual syndrome
InactiveUSRE38566E1Alleviate and/or prevent such adverse premenstrual symptomsBiocideCarbohydrate active ingredientsCarba mixPms premenstrual syndrome
A composition is disclosed for alleviating or managing symptoms associated with premenstrual syndrome "PMS" comprising an effective amount of an aqueous mixture of water and a rapidly digestible carbohydrate blend. The aqueous mixture is essentially free of protein and is characterized by a certain pH and ratio of water to carbohydrate blend. Methods of use of the composition for alleviating or managing symptoms associated with PMS are also disclosed.
Owner:WALDEN LAB
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Patsnap Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com